Wealth and Investing Center

Genzyme shares tumble after FDA statement

NEW YORK | Fri Nov 13, 2009 12:17pm EST

NEW YORK (Reuters) - Shares in Genzyme Corp GENZ.O fell 6.6 percent to $49.63 on Friday after the U.S. Food and Drug Administration said contamination was found in certain Genzyme drugs.

(Reporting by Edward Krudy)
Hot Stocks
Asian Markets
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.